Anavex Life Sciences Corp - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
AVXL Nasdaq 8731 https://www.anavex.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Anavex Life Sciences Corp

ANAVEX®2-73 (Blarcamesine) Shows Clinical Benefit in Long-Term 48-Week Phase 2 Extension Study in Patients with Parkinson’s Disease Dementia - Mar 30th, 2023 11:00 am
Wall Street Thinks This Small-Cap Stock Can Quadruple in Value - Mar 15th, 2023 1:53 pm
Acadia (ACAD) Gets FDA Approval for Daybue for Rett Syndrome - Mar 13th, 2023 2:19 pm
Anavex Life Sciences Appoints Former FDA Lead Neurology Statistician as Vice President Head of Biostatistics - Mar 9th, 2023 12:00 pm
Why Shares of Anavex Life Sciences Rose 12.4% in February - Mar 7th, 2023 1:21 am
Is Anavex Life Sciences Stock a Buy Now? - Feb 23rd, 2023 3:00 pm
Does Anavex Life Sciences (AVXL) Have the Potential to Rally 270.28% as Wall Street Analysts Expect? - Feb 15th, 2023 2:55 pm
This Short-Squeeze Candidate Could Actually Pan Out in the Long Run - Feb 9th, 2023 1:45 pm
Anavex Life Sciences Corp. (NASDAQ:AVXL) Q1 2023 Earnings Call Transcript - Feb 8th, 2023 7:36 pm
Why Anavex Life Sciences Stock Bolted Higher in January - Feb 8th, 2023 3:16 pm
Anavex Life Sciences Stock Shows Improved Price Strength Rating - Feb 7th, 2023 7:33 pm
Anavex Life Sciences Reports Fiscal 2023 First Quarter Financial Results - Feb 7th, 2023 12:00 pm
Anavex Life Sciences Announces Exceeding of Enrollment Target for the ANAVEX®2-73 (blarcamesine) EXCELLENCE Phase 2/3 Rett Syndrome Clinical Trial - Feb 2nd, 2023 12:00 pm
Anavex Life Sciences to Announce Fiscal 2023 First Quarter Financial Results on Tuesday February 7, 2023 - Jan 31st, 2023 12:00 pm
We Think Anavex Life Sciences (NASDAQ:AVXL) Can Easily Afford To Drive Business Growth - Jan 23rd, 2023 2:11 pm
FDA Rejects Accelerated Nod to Lilly's (LLY) Alzheimer's Drug - Jan 20th, 2023 5:52 pm
3 Biotech Stocks Under $15 Worth a Second Look in 2023 - Jan 18th, 2023 1:00 pm
Anavex Life Sciences Stock Could 5x Before 2025 -- Here's Why - Dec 17th, 2022 2:15 pm
Anavex Life Sciences Corp. (NASDAQ:AVXL) Q4 2022 Earnings Call Transcript - Dec 15th, 2022 4:19 pm
Anavex Strengthens Scientific Advisory Board with Investigator from Phase 2b/3 Alzheimer’s Trial - Dec 14th, 2022 12:00 pm